Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Gin to disinfectant: Belgian distillery joins fight against coronavirus

Published 2020-03-21, 07:21 a/m

By Bart Biesemans and Jeremy Audouard

WICHELEN, Belgium (Reuters) - A Belgian distillery has switched from producing gin to disinfectants after medical authorities sought additional supplies to cope with coronavirus spreading in the country.

The Belgian government said on Friday it would provide 1 billion euros ($1.1 billion) urgently to help hospitals face the crisis, with 2,257 cases confirmed so far and 37 deaths recorded.

In the town of Wichelen, the Rubbens distillery decided to play its part: it started treating the alcohol that normally goes into gin and genever - a juniper-flavored liquor - with ether, producing a disinfectant liquid for hands and surfaces.

"Hospitals started calling us to ask if we had alcohol," said the company's manager, Hendrik Beck. "Last week, we were bottling gin. Now, we're filling up disinfectant alcohol. It's pretty unreal for us, but we are happy to help out people."

Rubbens normally produces around 4,000 liters of liquors a day - now, it's 10,000 liters of the disinfectant instead.

As the country went into a lockdown to try contain the disease, Beck said the distillery was among the many businesses hit, and selling the newly made liquid went only some way to offset the damage.

"Our company is suffering economic losses - our bar and restaurant are closed, and our clients are also affected a lot," he said. "We can compensate for this a bit now, but we wouldn't want anything else but for everything to go back to normal."

© Reuters. Belgian distillery switches its production from gin to disinfecting alcohol in Wichelen

The Belgians are not alone. LVMH, the conglomerate behind Louis Vuitton, has said perfume factories in France, which normally turn out fragrances and cosmetics for Christian Dior, Guerlain and Givenchy, would start producing sanitizer gel to be distributed free to hospitals and health workers.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.